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ABSTRACT
HepatitisCvirus(HCV)RNAisrecognizedandcleaved
invitrobyRNase Penzymenear theAUGstartcodon.
Because RNase P identifies transfer RNA (tRNA) pre-
cursors, it has been proposed that HCV RNA adopts
structural similarities to tRNA. Here, we present
experimental evidence of RNase P sensitivity conser-
vation in natural RNA variant sequences, including a
mutant sequence (A368–G) selected in vitro because
it presented changes in the RNA structure of the rel-
evantmotif.Thevariationdidnotabrogatetheoriginal
RNase P cleavage, but instead, it allowed a second
cleavage at least 10 times more efficient, 4 nt down-
stream from the original one. The minimal RNA
fragment that confers sensitivity to human RNase
P enzyme was located between positions 299 and
408 (110 nt). Therefore, most of the tRNA-like domain
resides within the viral internal ribosome entry site
(IRES) element. In the variant, in which the mutation
stabilizes a 4 nt stem–loop, the second cleavage
required a shorter (60 nt) substrate, internal to the
minimal fragment substrate, conforming a second
tRNA-like structure with similarities to a ‘Russian-
doll’ toy. This new structure did not impair IRES
activity, albeit slightly reduced the efficiency of
translation both in vitro and in transfected cells.
Conservation of the original tRNA-like conformation
together with preservation of IRES activity points to
an essential role for this motif. This conservation is
compatible with the presence of RNA structures with
different complexity around the AUG start codon
within a single viral population (quasispecies).
INTRODUCTION
Hepatitis C virus (HCV) genome consists of a single-stranded
RNA of approximately 9600 nt in length with a plus polarity.
Sequence analysis of a large number of complementary DNA
(cDNA) clones of HCV from single isolates has provided
evidence that the HCV genome cannot be deﬁned by a single
sequence, but rather by a population of variant sequences
closely related to one another (1). This manner of organizing
the genetic information, which characterizes most RNA vir-
uses, is called quasispecies (2). It is theoretically predicted
that, after RNA folding, part of the variability present in the
RNA sequences of the viral population may still be represen-
ted in secondary or tertiary RNA structures, providing altern-
ative conformations (3). This variability could potentially
modify the strength of RNA conformational signals, which
represent potential substrates for selection events, or provide
the signals with different meanings. Nevertheless, the predict-
able phenomenon related to RNA structural variability in viral
quasispecies has not been extensively evaluated experiment-
ally, probably because it is difﬁcult to identify variant struc-
tures among very similar sequences.
HCV RNA comprises a 50 untranslated region that functions
as an internal ribosome entry site (IRES, Figure 1). The highly
structured IRES comprises most of the 50 untranslated
sequence (4) and extends in the AUG downstream sequence,
possibly including 30 nt of the core coding sequence (5–8).
Although the exact 30 boundary of the HCV IRES is subjected
to controversy, it is clear that the activity of the IRES can be
profoundly inﬂuenced by the nature of the immediate down-
stream coding sequences [(reviewed in (9)].
In a previous work, we identiﬁed two positions within the
viral genome that were cleaved in vitro speciﬁcally by human
RNase P, the enzyme that processes tRNA precursors (pre-
tRNA)(10).One ofthesusceptible positionsislocatedatthe 30
vicinityofthe initiator AUG codon (Figure 1).Recently, itwas
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doi:10.1093/nar/gki290shown that the catalytic RNA from RNase P of Synechocystis
sp. also cleaved speciﬁcally at the 50 vicinity of the AUG
codon (11). RNase P cleavage is not a unique property of
the HCV genome. Cleavage by human RNase P has been
mapped in a similar position near the AUG of the related
animal pestiviruses, CSFV (classical swine fever virus)
and BVDV (bovine viral diarrhea virus), and has been
detected near the initiation codon of other unrelated RNA
virus families (12).
Substrate recognition by RNase P is structure dependent
(13). RNase P cleavage has reliably identiﬁed a number of
authentic tRNA-like domains in non-tRNA molecules, includ-
ing bacterial SRP (signal recognition particle) RNA and
tmRNA (transfer-messenger RNA), and various plant viral
RNA genomes (14–18). Recognition of HCV RNA by the
RNase P enzyme and the ability of HCV RNA to compete
with pre-tRNA processing by this enzyme have led to propose
that viral RNA adopts internally a structural motif similar to
Figure 1. Diagramofgenotype1bHCVIRESRNAsecondarystructure(sequence2–418usedinthiswork)modifiedfrom(25).SubstitutionsC204UandA214Uin
the WT sequence are indicated; the A368G sequence only differs from the WT sequence by the A368G mutation. A double arrow indicates RNase P cleavage site
(361–363).Alinebetweennucleotides339and361depictsthehybridizationsiteofaDNAprimerusedforinvitroselectioninFigure2.Structuralsub-domainsare
indicated from I to IV.
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the tRNA-like structures found in HCV RNA is unknown
(10), the proximity of one of the RNase P substrates to the
AUG suggests that it may have a role in the initiation of viral
RNA translation, probably by recruiting small ribosomal sub-
units (12). In fact, HCV IRES does not require all the canon-
ical initiation factors to recruit the ribosome, and is able to
directly bind the 40S subunit (19,20). Various studies have
pointed out the importance of stable independent structural
RNA domains in the IRES for ribosome recruitment
(19,21–23). Furthermore, it has been shown that this interac-
tion, as well as the HCV IRES RNA structure, is magnesium
dependent (19,24).
With this in view, we have made efforts to characterize the
minimal tRNA-like domain, and indirectly assess its relevance
within the viral life cycle, by measuring its degree of conser-
vation either in different patients or in a single patient quas-
ispecies, as well as its effect in IRES-dependent translation.
In this study, we used human RNase P enzyme as a tool to
study the tRNA-like motif located near the translation initi-
ation codon of HCV RNA. We characterized this structural
motif using a population-based approach, as would be deﬁned
by a population geneticist. The reason was that the population
of HCV RNA molecules is highly variable and that variability
in the primary structure may be expressed in the ﬁnal con-
formation RNA adopts. The analysis was conducted along
three consecutive phases: in the ﬁrst, we analyzed the
sequence composition of the viral population of sequences
around the AUG codon in several patients and assayed the
RNase P enzyme accessibility in the variant RNAs. In the
second, we selected in vitro a conformational variant from
a population of sequences from a single patient; in the
third, we characterized the tRNA-like domain of the con-
formational variant and of the most frequently represented
sequence in the total population. Characterization included
the following comparative studies: (i) in vitro sensitivity to
RNase P; (ii) minimal fragment length requirement and loc-
alization in the viral genome; (iii) secondary RNA structure
probing; and (iv) in vitro and in cell culture efﬁciency of
internal initiation of translation. Direct analysis of RNA
integrity showed that the HCV RNA is not accessible to
RNase P in the cytoplasm of transfected cells, strongly sug-
gesting that this conserved tRNA-like motif may provide
a signal for HCV RNA life cycle, different from RNA
processing.
MATERIALS AND METHODS
Clinical and virological characteristics of the
HCV infected patients in the study
We selected eight patients infected with hepatitis C virus at
different stages of the disease. One (Patient 1) was in the acute
phase of the disease. The others were chronically infected, one
(Patient 2) with mild, two (Patients 3 and 4) with moderate
and, and three (Patients 5, 6 and 7) with severe liver damage.
The last one (Patient 8) presented liver cirrhosis. Viral loads
ranged from 10
5 genome copies/milliliter in patient 2, to 107
copies/milliliter in patient 1. No one has been previously trea-
ted and they were not co-infected with other hepatitis virus or
human immunodeﬁciency virus.
RNA extraction, RT–PCR, cloning and sequencing
Viral RNA was extracted from serum samples (140 ml) from
HCV-infected patients (Patients 1–8) with the QIAamp viral
RNA mini kit (Qiagen). Isolated HCV RNA was reverse-
transcribed into cDNA, with a genotype 1b-speciﬁc primer
from the IRES-core region (CORE 419( )5 0-CCACCAACG-
ATCTGACCACCG), and nested PCR was then performed
to obtain the 2–418 fragment [outer set: 50-2(+)5 0-CGCG-
GATCCGGCCGCCCCGATTGGGGGCGA and CORE
419( ) inner set 50 T7-2(+)CGCGGATCCTAATACGACT-
TAATACGACTCACTATAGGCCGCCCCGATTGGGGGC-
GA (BamHI cloning site underlined) and CORE 394( )
50-CCGGAATTCCCCGGGAACTTGACGTCCTGTGGGC
(EcoRI cloning site underlined)].
T7-HCV 2–418 DNA molecules were cloned in a pUC18
vector between the BamHI and EcoRI restriction sites and
transformed in the Escherichia coli DH5a strain. Individual
clones were sequenced by the dideoxy chain terminator method
with the DNA sequencing kit (ABI PRISM dRhodamine
Terminator Cycle Sequencing Ready Reaction kit, Applied
Biosystems) using M13 and reverse M13 primers and analyzed
in an ABI PRISM 310 Genetic Analyzer (Applied Biosystems).
We performed an analysis of the sequence composition of
the viral quasispecies of the 50 NCR-core junction region,
around the 50 RNase P cleavage site (361–363), from positions
23 to 393. A total of 155 HCV cDNA clones were sequenced
from the eight infected patients described before. Sequences
were then compared and the predominant and mutant
sequences were identiﬁed for each patient.
In vitro selection
Step 1: We started with the HCV RNA viral sequence popu-
lation extracted, reverse-transcribed and ampliﬁed in serum
from Patient 5. We obtained DNA fragments containing the
phage T7 promoter sequence followed by DNA corresponding
to positions 2–418 of the HCV genome (see previous section
and Figure 2).
Step 2: Ampliﬁed HCV DNA 2–418 molecules were tran-
scribed in vitro in the presence of [a-
32P]GTP, and the labeled
RNA transcripts were polyacrylamide gel-puriﬁed and quan-
tiﬁed in a scintillation counter (for more details see ‘In vitro
transcription’ section).
Step 3: The labeled RNA mixture was subjected to DNA-
mediated RNase H cleavage using a DNA oligonucleotide
complementarytonucleotides339–361ofHCVRNA.Withthis
preliminary kinetic experiment, we determined the incubation
time of the reaction that released 50% of the product bands.
Step 4: Once the experimental conditions to cleave 50% of
RNA transcripts had beendetermined, a preparative experiment
was performed and non-cleaved RNAs were gel excised, eluted
from gel and ethanol precipitated. They were quantiﬁed and
againsubjectedtoRT–PCR,whichbegananewselectioncycle.
Four selection cycles were performed. DNA fragments
obtained after step 1 were cloned in E.coli and 20 clones
were sequenced after cycles 0, 2 and 4.
Obtaining shorter HCV DNA templates for
transcription
In order to deﬁne the RNase P minimal sequence length
requirement, nine shorter DNA templates were consecutively
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2–418 (WT and A368G). The oligonucleotide sequences used
were 50T7 291(+): 50-TAATACGACTCACTATAGGGC-
CATGGCCTGATAGGGTGCTTGCGA (G291 underlined);
50T7 299(+): 50-TAATACGACTCACTATAGGGTGCTTG-
CGAGTGCCCCG; 50T7 311(+): 50-TAATACGACTCAC-
TATAGGTGCCCCGGGAGGTCTCGTAG; 50T7 331(+):
50-TAATACGACTCACTATAGACCGTGCACCATGAGC-
ACG; CORE T7 350(+): 50-TAATACGACTCACTATA-
GAATCCTAAACCTCAAAGGA; CORE 418( ): 50-CCG-
GAATTCCCCGGGAACTTGACGTCCTGTGGGC
394 (418
position underlined); CORE 408( ): 50-
408TGACGTCC-
TGACGTCCTGTGGGCGGCGG
389; CORE 398( ): 50-
398
TGGGCGGCGGTTGGTGTTAC
379; CORE 390( ): 50-
390
GGTTGGTGTTACGTTTGGTTTT
369; CORE 380mut( ):
50-
380ACGTTTGGTTTTCCTTTGAGG
360 (A368G mutation
underlined).
In vitro transcription
RNA transcripts were obtained from the PCR DNA mixture
(in vitro selection procedure), from EcoRI (2–418 HCV)
or FokI (pUC19TyrT) linearized plasmids, or from the PCR
products.
Transcription reactions were carried out as previously
described (10). Brieﬂy, 1 mg DNA template was transcri-
bed in vitro (37 C, 1 h) with [a-
32P]GTP or [a-
32P]ATP fol-
lowed by 5 min of treatment with RNase-free DNase I at 37 C.
Cellulose CF11 chromatography was used to eliminate DNA
fragments and non-incorporated nucleotides. Transcripts were
then puriﬁed by gel electrophoresis under denaturing condi-
tions on 4% polyacrylamide gels containing 7 M urea. Fol-
lowing X-ray ﬁlm exposure, RNAs were excised from the gel
and eluted in 10 mM Tris–HCl (pH 7.5) and 1 mM EDTA
(pH 7.5). The concentration of radioactive transcripts was
determined by calculating the amount of incorporated
[a-
32P]GTP or [a-
32P]ATP based on scintillation counting.
For in vitro translation experiments, the HCV IRES pre-
dominant and A368G mutant 2–418 sequences were cloned in
a bicistronic vector with the 26 ﬁrst amino acids of HCV core
protein fused in frame with the ﬁreﬂy luciferase. RNAs
were obtained by in vitro transcription using T7 promoter
and the MEGAscript high yield transcription kit (Ambion).
RNA size was assessed by agarose gel electrophoresis and
RNAs were quantiﬁed by trace radiolabeling.
RNA structure comparison between WT and
A368G RNAs
DNA-directed RNase H cleavage. RNase H cleavage experi-
ments were carried out according to a previously described
method (25). The DNA primer complementary to HCV RNA
339–361 used in the in vitro selection experiment was
50-GGGTTTAGGATTCGTGCTCATGGT. Puriﬁed RNA
transcripts were resuspended at a concentration of 0.6 nM
in the reaction mixture, DNA primer complementary to
HCV IRES was added at a ﬁnal concentration of 15 nM,
with 250 ng carrier tRNA in 20 mM HEPES pH 8.0,
50 mM KCl, 10 mM MgCl2 and 1 mM DTT, and ﬁnally,
0.5 U RNase H (Promega) was added in a ﬁnal volume of 5 ml.
Figure 2. Schematic representation of in vitro selection procedure for isolating natural HCV IRES RNA structure variants using RNase H/DNA oligonucleotide-
mediated cleavage of HCV mRNA. See Materials and Methods for details.
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experiments. Reactions were stopped by addition of 10 ml gel
loading buffer and stored on ice. Reaction products were ana-
lyzed on denaturing 4% polyacrylamide gel containing 7 M
urea and visualized by autoradiography.
RNase P cleavage. RNase P was previously puriﬁed in the
laboratory from HeLa cells (10). RNA transcripts at a 1.8 nM
ﬁnal concentration were pre-heated for 1 min at 90 C before
addition of reaction buffer (10 mM HEPES–KOH pH 7.5,
10 mM MgOAc, 100 mM NH4OAc) and left to cool for
20 min to room temperature. Cleavage reactions were per-
formed for 30 min at 30 C in a ﬁnal volume of 10 ml with
4% polyethylene glycol 8000, 20 U of RNase inhibitor RNasin
(Promega) and 1 ml of RNase P peak activity. (pre)tRNA
tyr
was used as substrate for human RNase P as positive control in
some reactions.
Reaction products were electrophoresed on denaturing
polyacrylamide gels containing 7 M urea and visualized by
autoradiography.
For some experiments, RNase P cleavage efﬁciency was
measured using a Radioisotopic Image Analyser FLA-5000
(Fuji). Quantitative data were obtained from triplicate experi-
ments, average cleavage efﬁciency percentage was calculated
as the ratio: products/products + uncleaved RNA.
RNA structure mapping with nucleases.
RNase T1 assays on uniformly labeled transcripts: Labeled
RNA transcripts were mixed at a ﬁnal concentration of
0.375 nM with 4 mg carrier tRNA in 10 mM HEPES–KOH
(pH 7.5),10 mMMgOAc,100 mMNH4OAcand1mg/ml(total
cleavage)or0.03mg/ml(partialcleavage)RNaseT1wasadded
inaﬁnal volumereactionof20ml.Reactionswere incubatedat
37 C, 20 min and analyzed on a denaturing 20% polyacryl-
amide gel containing 7 M urea. Results were visualized by
autoradiography.
RNases T1, A and V1 assays on end-labeled transcripts:I n
order to obtain 30 end-labeled transcripts, uniformly labeled and
unlabeled ‘cold’ RNAs were both transcribed, run in parallel and
bandswereelutedfromacrylamidegel.The‘cold’transcriptwas
subsequently labeled with T4 RNA ligase and [
32P]pCp 50 tri-
phosphate under conditions similar to those described by the
manufacturer. The reaction was carried out in 30 mlo f5 0m M
Tris–HCl pH 7.5, 10 mM MgCl2,1 0m MD T T ,1m MA T P ,
0.01% BSA and 10% DMSO. The reaction mixture was incub-
atedfourdaysat4 C. The labeled RNA was puriﬁed again using
the electrophoretic procedure described above. For the 50 end-
labeled transcript preparations, ‘cold’ transcripts prepared as
beforewerelabeledwith[a-
32P]GTPusingtheenzymeguanylyl
transferase, and followed the same puriﬁcation procedure.
For RNase reactions, the digestion mixture (10 ml) con-
tained about 10
4 Cerenkov cpm of the 50 or 30 end-labeled
transcript and 2.5 mg of carrier tRNA in 10 mM HEPES–KOH
(pH 7.5), 10 mM MgOAc, 100 mM NH4OAc. The cleavage
reaction was initiated by addition of 0.001 mg/ml nuclease T1,
10
 7mg/mlribonucleaseAand0.001mg/mlnuclease V1incub-
atedat37 Cfor20min(T1andA),or10min(V1).Forlimited
alkaline hydrolysis reaction, 10
4 Cerenkov cpm of end-labeled
RNA (1/10 volume) were incubated with 2.5 mg of carrier
tRNA in 0.2 M NaHCO3–Na2CO3 pH 9 and 1 mM EDTA
for 6.5 min at 90 C (9/10 volume).
The reactions were stopped by addition of two volumes
of gel loading buffer, and products were resolved on 20%
denaturing polyacrylamide gel. Gels were visualized by auto-
radiography.
Northern blot analysis
Inorder tofacilitatethe testofRNasePcleavage ofHCV RNA
in cells’ cytoplasm, the HCV299–408 sequence was inserted
within the ﬁrst cistron of plasmid pBIC previously described
(26).This bicistronic vector contains the sequence of phage T7
promoter, the Chloramphenicol Acetyltransferase (CAT) cod-
ing sequence, the sequence of the Foot-and-Mouth Disease
virus (FMDV) IRES and the luciferase coding sequence.
The sequence of the HCV299–408 (WT) was ampliﬁed by
PCR and introduced in pBIC at a unique NcoI restriction
site, located in the CAT coding sequence.
Transfection of 80–90% conﬂuent BHK-21 monolayer was
carriedoutusingcationic liposomes1hafterinfection withthe
vaccinia virus VTF7-3, expressing T7 RNA polymerase in the
cell cytoplasm (27).
Total RNA was extracted 16 h post-transfection, using the
Tripure isolation Reagent (Roche). Time course expression
assays visualized by northern analysis revealed that this was
the optimal time of collection for newly transcribed bicistronic
RNA with or without HCV RNA insert (data not shown). RNA
(10 mg) was electrophoresed in a 1.5% agarose gel containing
2.2 M formaldehyde, 20 mM MOPS, 5 mM Na-Acetate and
1 mM EDTA. Electrophoresis buffer contained 20 mM MOPS,
5 mM Na-Acetate and 1 mM EDTA. Ethidium bromide was
addeddirectlytoRNAsamplesinordertocontroltheRNAinput
and the transfer efﬁciency. Transfer was performed by capillary
blotting to a nylon membrane (Hybond-N+, Amersham Phar-
macia Biotech) as indicated by the supplier.
Hybridization and detection was performed using the
North2South Direct HRP Labelling and Detection kit (Pierce).
The probes used were CAT 1–100 (100 bp), obtained by PCR
from pBIC plasmid and HCV299–408 (PCR product used to
obtain the pBIC-HCV plasmid).
In vitro and in vivo IRES activity
In vitro translation was performed in 50% rabbit reticulocyte
lysate, 10 mM HEPES–KOH (pH 7.5), 0.5 mM MgOAc,
100 mM NH4OAc, 90 min at 30 C. Activity of IRES was
quantiﬁed as the ratio of ﬁreﬂy luciferase on renilla luciferase
using the Dual-Luciferase system (Promega).
Relative IRES activity was quantiﬁed in vivo as the expres-
sion of ﬁreﬂy luciferase normalized to that of renilla luciferase
from bicistronic mRNAs in transfected cells with previously
described full capacity to initiate translation from HCV IRES
(28–30). Transfection of 80–90% conﬂuent BHK-21 mono-
layers was carried out using cationic liposomes, 1 h after
infectionwiththeVacciniavirusrecombinantvTF7-3express-
ing the T7 RNA polymerase (27). Extracts from 1–2 · 10
5
cells were prepared 20 h post-transfection in 100 mlo f5 0m M
Tris–HCl, pH 7.8, 120 mM NaCl, 0.5% NP40 (31).
Accession numbers
The nucleotide variant sequences for the hepatitis C virus 50
non-coding region-core (50 NCR-core) region described have
been deposited in the GenBank database, accession numbers
Nucleic Acids Research, 2005, Vol. 33, No. 5 1491AY576547–AY576603. Among these sequences, the four
sequences from Patient 8 used for RNase P in vitro cleavage
are AY576565 (Var 1), AY576574 (Var 2), AY576575(Var 3)
and AY576577 (Var 4). The WT and A368G sequences from
HCV are, respectively, AY576552 and AY576555.
The nucleotide sequence of the reference 1b genotype HCV
used in this study is available at the GenBank database under
accession number S62220 (32).
RESULTS
Accessibility to RNase P in vitro is conserved despite
HCV RNA primary sequence variation
In this study, we performed a detailed analysis of the viral
quasispecies sequence composition of the 50 NCR-core junc-
tion region (Figure 1), around the 50 RNase P cleavage site.
Changes in primary sequence may compromise structural
organization required for optimal translation initiation, the
most relevant function mapped to this region of the HCV
genome. The characteristic quasispecies structure was found
in a total of 155 sequences derived from eight patients. This
includes a more frequent sequence in the population and a
variable spectrum of mutants that was observed in all samples,
as expected (1). A distinct consensus sequence was found in
most of the samples analyzed, with the exception of viruses in
three cases, which coincided with the 1b genotype standard
sequence all along the IRES element and the beginning of the
core-coding region. We subsequently compared the HCV mut-
ant spectrum in the eight samples analyzed and found that a
distinct, unique mutant spectrum accompanied each predom-
inant sequence in the eight viral quasispecies. Notably, four
variant sequences found in one of the samples studied presen-
ted mutations close to the RNase P cleavage site (Figure 3A),
within the previously described tRNA-like motif (10,12).
Because of the potential involvement of this structured region
in internal translation initiation efﬁciency, we compared
RNase P accessibility in parallel to the standard 1b genotype
sequence. To this end, we used transcripts from cloned HCV
PCR fragments, representing the predominant sequence as
well as low frequency sequences from one infected patient
(Patient 8) with mutations in the vicinity of the scissile bond
(Var 1–4, Figure 3A). Cleavage with similar efﬁciency was
consistently observed in triplicate experiments among natural
variant sequences (Figure 3B), strongly suggesting that the
RNA structural motif recognized by RNase P in vitro was a
relevant feature of the HCV RNA. Decrease in the cleavage
efﬁciency observed here in comparison with previous pub-
lished results could be due to the use of different RNase P
puriﬁed fractions, together with the use of a shorter HCV RNA
substrate (10,12).
Isolation of a structural variant from HCV RNA
quasispecies by an in vitro selection procedure
Taken together, the results in the previous section indicated
that it would be laborious to ﬁnd an altered RNA structure
around the RNase P cleavage site by systematic testing of all
the nucleotide mutants found in the viral quasispecies. In vitro
selection of a variant carrying an altered RNA structure in the
relevant motif was considered as a more direct approach.
RNase H was chosen as an ‘easy-to-use’ system for select-
ing potential HCV RNA conformation variants in the region
close to human RNase P in vitro cleavage (Figures 1 and 2).
We selected the sequences that were partially resistant to
RNase H. DNA-mediated RNase H cleavage is sequence spe-
ciﬁc, but depends on previous hybridization of a DNA oligo-
nucleotide to the target RNA, which in turn depends on RNA
accessibility. We took the advantage offered by a previous
study (25) that identiﬁed the HCV RNA fragment, encom-
passing nucleotides 339–361, as a relatively open region
that allows efﬁcient DNA-mediated RNase H cleavage in a
reference genotype 1b sequence.
The HCV RNA natural population of variants from one of
the eight patients [selected from a previous study because he
presented one of the most heterogeneous HCV RNA quasi-
species found in our laboratory, see (33): Table 1, patient 29]
was subjected to in vitro selection using RNase H in the
presence of a DNA oligonucleotide complementary to HCV
RNA (positions 339–361), close to the HCV 50 IRES RNase P
cleavage site (Figures 1 and 2).
Selected HCV 2–418 RNA molecules were cloned and
sequenced after two and four rounds of in vitro selection.
Twenty clones were sequenced and compared to sequences
cloned before the selection procedure, representing the
serum HCV quasispecies (cycle 0). One point mutation,
A368G,presentin10%ofthesequencesinserum,wasenriched
up to 50% of the sequences after four selection cycles. The
predominantsequenceinthispatient’sHCVRNAquasispecies
is called wild-type (WT) all along this work and contains the
mutations C204U and A214U when compared to the reference
genotype1bsequence.TheA368GRNAsequencediffersfrom
the WT sequence only by the A368G mutation (see Figure 1).
A368G mutation decreases RNase H accessibility
in HCV2–418 RNA
To prove that the variant sequence being selected adopts a
different RNA folding near the RNase P cleavage site, we
performed a comparative analysis of the RNA sequences con-
taining the mutation A368G or the WT RNA sequence with
ribonucleases known to have structure-dependent activities.
RNase H. To conﬁrm the phenotype of the in vitro selected
sequence,acomparative kineticRNaseHcleavageexperiment
was performed on independently transcribed RNAs containing
or not the selected mutation (A368G) (Figure 4). The kinetics
of cleavage were clearly different and, as expected, it appeared
that the mutant sequence was more resistant to RNase H cleav-
age than the WT sequence (Figure 4A, 3-fold effect). The
relative resistance to cleavage by RNase H was observed in
several experiments and was not due to a direct mismatch
between the DNA oligonucleotide and RNA, since the
mutation lies outside of the oligonucleotide hybridization
site (Figure 1).
Additional RNase H kinetic experiments were performed to
determine whether the A368G mutation induced other changes
in RNA accessibility over the entire IRES than the one
observed between nucleotides 339 and 361 (Figure 4B).
Whereas HCV mutant RNA showed slightly reduced access-
ibility for RNase H cleavage when using a DNA oligonuc-
leotide hybridizing to nucleotides 348–367 just upstream
from the mutation site, DNA oligonucleotides encompassing
1492 Nucleic Acids Research, 2005, Vol. 33, No. 5Figure3.RNasePsensitivityofHCVRNAnaturalvariantsbearingsubstitutionsintheRNasePcleavageregion.(A)Sequencealignmentofnucleotides241–418of
clonedHCVvariants.1brepresentsthegenotype1breferencesequenceandvariants1–4,fourHCVvariantsisolatedthroughcloningandsequencingof2–418region
ofHCVRNA(lowercase,HCV50 NCR,uppercase,HCVcorecodingregion).RNasePcleavagesiteisunderlinedatpositions361–363.Thepositionofthe30 primer
usedforPCRandcloningisunderlined(394–418).(B)AutoradiogramofRNasePinvitrocleavageassayoflabeled2–418HCVRNAs.Variants1–4wereincubated
withRNaseP,inparallelto1bHCVRNAcontrol,1h30minat30 C.ICEindicatestheinputRNA,notincubated.Reactionproductswerefractionatedindenaturing
polyacrylamide–UREAgelelectrophoresisfollowedofX-rayfilmexposure.Thearrowindicatesthelargercleavageproduct.Experimentwasrepeatedasatriplicate
andquantifiedwithaRadioisotopicImageAnalyserFLA-5000(Fuji).ThetablebelowtheautoradiogramindicatestheaveragecleavageofeachRNAdeterminedas
the ratio: products/products + uncleaved RNA.
Nucleic Acids Research, 2005, Vol. 33, No. 5 1493nucleotides 24–43, 279–303, 321–342, 324–348 and 369–388
were seen to have the same cleavage kinetics in both WT and
A368G HCV RNA. Thus, it seems that the A368G mutation
induces a local structural reorganization affecting residues
339–367 of HCV RNA.
RNase P. To examine whether the structural changes between
WT and A368G RNAs affected the tertiary RNA structure,
which confers similarity to tRNA in the reference genotype 1b
sequence, we tested in parallel the reference 1b, WT and
A368G sequences with the human structure-dependent
RNase P enzyme. This experiment revealed that A368G
RNA is associated with strongly increased sensitivity to
human RNase P (a more than 10-fold effect, Figure 4C),
whereas WT and 1b RNAs are equally recognized by this
enzyme.
HCV IRES A368G RNA presents an additional
RNase P cleavage site as compared to WT RNA
Processing of mutant A368G by RNase P was not a simple
case of increased cleavage efﬁciency to a variant RNA sub-
strate. By analyzing cleavage products of shortened HCV
substrates (nucleotides 291–418) on more concentrated acryl-
amide gels, we found two differentially migrating bands (L for
Large and S for Short) in the variant RNA which can be
interpreted as the result of an additional cleavage event
(Figure 5A), not present in the WT RNA. Parallel electrophor-
esis of the WT and A368G RNA cleavage products showed a
common pair of cleavage bands, both in position and intensity
(79/80 and 62/61 nucleotide products) and a second pair of
bands that were unique to the variant RNA (L and S). These
two new bands showed only a slight difference in migration in
the gel, but they were much more intense (Figure 5A).
Minimal HCV RNA substrate length necessary for
RNase P cleavage
To determine the minimal substrate necessary for RNase P
cleavage, WT and A368G HCV RNAs were sequentially shor-
tened and treated with RNase P (Figure 5B). The shortest WT
RNA processed by RNase P expanded from nucleotides 299 to
408 (110 nt, identical to the reference genotype 1b 299–408
sequence). However, cleavage efﬁciency was reduced and
minor cleavage products began to appear as compared to
Figure 4. Enhanced accessibility to RNase P of the in vitro selected HCV RNA variant partially resistant to RNase H. (A) Time course DNA-mediated RNase H
cleavage of the [a-
32P]GTP-labeled WT RNA compared to the A368G variant RNA (nucleotides 2–418), selected as indicated in Figure 2 using a DNA
oligonucleotide complementary to nucleotides 339–361 of HCV RNA. Products were analyzed by denaturing PAGE (4%) and visualized by autoradiography.
Thekineticstudy(0–90min)showstheresistantphenotypeassociatedwiththemutantnaturalvariant(estimatedata3-foldeffect).(B)RelativesensitivitiesofWT
and A368G 2–418 HCV RNA to DNA-mediated RNase H cleavage. The oligonucleotide column indicates the positions where DNA oligonucleotides hybridize to
RNA.+++:75–100%ofcleavageafter90min,++:50–75%.+:25–50%, :0–25%.(C)InvitrohumanRNasePcleavageofHCV2–418RNA.Lane1bisthecontrol
genotype1bHCVclonepreviouslyusedinthelaboratorytostudyRNasePcleavage(10)andrepresentsherethecleavageefficiencyandtheproductsizecontrol,lane
WT is theHCVpredominantsequenceofthepatient studiedhere,andlaneA368Gis the selectedmutantsequence.RNaseP(+) and( ) are,respectively,reactions
with and without RNase P. Products were analyzed by denaturing PAGE (4%) and visualized by autoradiography. The position of the two 50 and 30 end RNase P
cleavage products is indicated on the right.
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probably indicating a loss of speciﬁc activity.
With regard to the A368G RNA, the shortest A368G RNA
containing both RNase P cleavage sites [the ﬁrst site
previously described at position 361–363 (10) and the
‘new’ one] encompassed nucleotides 299–408, whereas the
next construct containing nucleotides 311–408 only allowed
for the ‘new’, and more effective, cleavage event. After
decreasing the length of the substrate, speciﬁc cleavage still
occurred in the fragment containing nucleotides 331–390, but
not in the shorter RNA containing nucleotides 350–390
(Figure 5B).
To determine the position of the new cleavage site, we used
an RNase T1 mapping strategy in a shortened A368G RNA
fragment (nucleotides 311–390), which was shown to be sub-
strate for human RNase P (see Figure 5B). Brieﬂy, the largest
RNasePcleavage productfrom 311–390 A368GRNA was gel
puriﬁed and subjected to RNase T1 complete digestion.
Digestion fragments were subsequently separated in 20%
acrylamide gel. The longer RNase T1 cleavage fragments
were identiﬁed as a doublet of 15 and 16 nt (Figure 5C),
when compared to the electrophoretic mobility of the 11,
12 and 17 nt bands in the control lanes, obtained after total
digestion of the 311–408 fragment. This showed that the major
RNase P cleavage in mutant A368G RNA occurs between
nucleotides 365 and 367, four nucleotides downstream from
the ﬁrst cleavage (see below, Figure 6C).
RNA secondary structure probing of the RNase
P substrate present in HCV RNAs
Experiments involving partial digestion of HCV A368G and
WT RNAs by single and double-strand RNA-speciﬁc
nucleases were performed in order to characterize possible
Figure 5. IdentificationoftheminimalsubstrateforRNasePcleavageintheinvitroselectedHCVRNAvariant.(A)ComparisonoftheRNasePcleavagepatternof
HCVWTandA368G.
32P-labelednaturalsubstrateforhumanRNaseP(pTyr),HCVWTandA368G291–418RNAsweresubjected(+)ornot( )toinvitroRNaseP
cleavage and analyzed on a 10% denaturing acrylamide gel. The arrows indicate the new cleavage products observed in A368G RNA, L (Large) and S (Short).
NumbersindicatethelengthinnucleotidesofRNAfragments.(B)DelimitationofthehumanRNasePminimalsubstratesinHCVWTorA368GRNAIRES.DNA
templates were obtained by PCR, in vitro transcribed, and subjected to in vitro RNase P cleavage. Positions of RNase P cleavage are indicated as 361/363 for the
previouslydescribedcleavagesite,andas‘new’forthecleavagesitedescribedinthiswork.(C)IdentificationoftheRNasePcleavageproducts.HCVmutantRNA
311–390wastreatedwithRNaseP.Then,the50 endlargecleavageproduct(L)wasgelpurifiedandsubjected(lane5)ornot(lane4)tototalcleavagebyRNaseT1.
Reactionproductswereanalyzedona 20%denaturinggelandcomparedtotheHCVmutantRNA311–390,alsosubjectedtoRNaseT1digestion(lanes1,2and3).
RNaseT1cleavagefragmentswereruninparalleltothoseobtainedatthesametimefromthe311–408controlRNAthatallowtheidentificationofthe11,12and17nt
bands(lanes6,7and8).NumbersontherightindicatethelengthinnucleotidesofRNAfragments.Thetablebelowthegeldepictsthesequenceofthe11,12and17nt
HCV mutant RNA RNase T1 resistant oligonucleotides.
Nucleic Acids Research, 2005, Vol. 33, No. 5 1495Figure6.EnzymaticstructuralprobingoftheminimalfragmentrecognizedbyRNaseP.(A)ComparisonofRNaseT1cleavagepatternofWTandA368Guniformly
ATP-labeled HCV RNAs (299–408). Left panel: A368G and WT RNA without RNase T1, or incubated with 0.03 or 1 mg/ml of RNase T1 during 20 min at 37 Ci n
RNase P incubation buffer (10 mM HEPES–KOH, pH 7.5, 10 mM MgOAc, 100 mM NH4OAc). Right panel: ‘A368G’: control reaction of mutant RNA incubated
with 0.03 mg/mlo r1mg/ml of RNase T1. ‘A368G-pre’: aliquot of HCV mutant 299–408 RNA cleaved by 0.03 mg/ml RNase T1, before gel purification of the 29 nt
product. ‘29 b’: gel-purified 29 nt product treated with or without 1 mg/ml RNase T1. Products were analyzed in denaturing PAGE (20%) and visualized by
autoradiography.XCindicatesxylenecyanoldyeposition(separatesasa28ntfragmentin20%acrylamidegel);numbersincolumnindicatethelengthinnucleotides
of RNA fragments. (B) RNase T1 partial digestion of 60 nt HCV 331–390 WT and A368G mutant RNAs. 30 end-labeled RNAs were incubated with 0.001 mg/ml
RNase T1, 20 min at 37 C and electrophoresed in a 20% acrylamide gel in parallel with one of the transcripts subjected to partial alkaline hydrolysis (OH-). (C)
Diagram of RNase T1 cleavage products in WT and A368G HCV RNA sequences (299–408). The
32P-labeled A residues appear in bold, G residues recognized by
RNase T1 are underlined, and position of the described RNase P cleavage site in genotype 1b RNA is indicated. Numbers and lines indicate the largest predicted
fragments. Position of the 29 nt product is also underlined.
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approaches were performed: (i) RNase T1 digestion of uni-
formly labeled transcripts and (ii) RNases T1, A or V1 partial
digestion of end-labeled transcripts. To allow a better resolu-
tion of the reaction products in acrylamide gels, short 110 and
60 nt transcripts were used in (i) and (ii), respectively. The
110 nt RNA fragment (nt 299–408) is the minimal substrate
for RNase P that is cleaved at both cleavage sites (361–363
and 365–367) and the 60 nt RNA fragment (nt 331–390) is
theminimalsubstrateintheA368GRNAforRNasePcleavage
at position 365–367 (see Figure 5B for details).
RNaseT1probingoftranscriptsbearingbothRNasePsites:
Thereactionbuffer,whichcontained10mM Mg
2+andwasthe
same as that used in the RNase P assays, ensured that the RNA
presented its magnesium-dependent structure (10,24). After
RNase T1 partial cleavage of [a-
32P] ATP-labeled HCV
RNA molecules, a 29 nt partial digest fragment was produced
in A368G RNA, but not in WT RNA (Figure 6A, left panel).
Same result was observed with [a-
32P]GTP-labeled RNAs
using a wide range of RNase T1 concentration (data not
shown). This partial digest fragment was gel puriﬁed and
subjected to complete RNase T1 digestion (Figure 6A, right
panel). The experiment showed that the 29 nt fragment sep-
arates into two visible fragments containing 11 and 17 nt. This
result indicates that the 29 nt fragment ishighly protected from
cleavage by RNase T1 at positions G367 and G368 in A368G
RNA (WT RNA contains only G367, Figure 6C). Residues
G367 and G368 are probably engaged in Watson–Crick base
pairing in A368G RNA, whereas G367 remains accessible to
RNase T1 cleavage in the WT sequence.
RNases T1, A and V1 assays using end-labeled transcripts:
WT and A368G 60 nt transcript were prepared, and sub-
sequently labeled independently at the 50 end with
[a-
32P]GTP and guanylyl transferase (‘cap’ labeled) or at
the 30 end with
32PpCp and T4 RNA ligase. Partial cleavage
digestion products were run in parallel to the corresponding
end-labeled transcript partially hydrolyzed by limited alkaline
hydrolysis procedure. The result of the partial digestion of the
30 end-labeled WT and A368G RNAs is shown in Figure 6B
that clearlyconﬁrms the protectionof residues G367 and G368
from RNase T1 cleavage in A368G RNA in the 60 nt
molecule.
Figure 7compiles the data of the positions protected from or
accessible to cleavage by the nucleases, represented in the
RNA structure for both WT and A368G 60 nt transcript
predicted with the RNA structure 3.5 program (34). A
stem–loop containing the AUG codon (nt 334–350) was pre-
dicted in both the WT and A368G sequences, in agreement
with the nuclease mapping shown here and the HCV IRES
secondary structure described up to now. The program also
predicts the formation in the A368G RNA, but not in the WT
RNA, of a stem–loop involving nucleotides 353–369. Enzym-
aticprobingexperiments,andespeciallyexperimentsusingthe
V1 nuclease, suggest that, in the WT sequence, a stem–loop
could be formed implying the formation of a shorter stem
between nucleotides 355–356 and 366–367 (which was thus
Figure 7. Summary of secondary structure probing of HCV 331–390 (WT and A368G) RNAs. Sensitivity to various RNases is indicated on the predicted RNA
structure. HCV331–390 WT structure was forced for base pairing between CU355–356 and AG366–367. HCV331–390 A368G was predicted by RNA structure
3.5 program (34) (only one structure was predicted). Arrows indicate cleavages by single-strand-specific RNases T1 and A, whereas triangles show cleavage by
double-strand-specific RNase V1. Nucleotide numbering is used as in Figure 1 (50–30 orientation).
Nucleic Acids Research, 2005, Vol. 33, No. 5 1497represented in Figure 7). Additionally, some nuclease V1
cleavage events were located at positions 374–375 and
387–388 in an A-rich region actually sensitive to RNases A
and T1 and predicted as single-strand. This could be explained
by an RNA structure independent of Watson–Crick base
pairing.
RNase P does not cleave HCV 50 tRNA-like motif in
the cytoplasm
Because RNase P is a nuclear enzyme and the virus replicates
in the cytoplasm, it is unlikely that the RNase P processes the
HCV RNA in vivo. Nevertheless, it cannot be discarded that a
fraction of the enzyme is present in the cytoplasm, e.g. during
biosynthesis or during transportation to mitochondria. The
activity of RNase P in the cytoplasm would cleave HCV
tRNA-like motif. We inserted the HCV299–408 minimal sub-
strate of the 1b reference sequence into a bicistronic construct
(Figure 8A) and evaluated by northern analysis the presence of
speciﬁc cleavage at the tRNA-like structure (Figure 8B). Two
independent probes were used for hybridization, one corres-
ponding to the vector CAT coding region (Figure 8B, left
panel) and the other to the HCV insert (Figure 8B, right
panel). Using the CAT probe, several bands were observed
either in the control without insert (Figure 8B, lane pBic) or in
the RNA containing the HCV insert (Figure 8B, lane HCV).
Theupper-mostbandbelowthe28SRNAmarker,corresponds
to the expected full-length transcript, the other bands could
represent either premature stops in transcription or processing
by endogenous nucleases. Examination of band pattern
revealed that the only difference occurs in the mobility of
the bands migrating below the 18S RNA marker that could
be attributed to the HCV sequence insertion (110 nt). No new
transcripts appeared in the HCV lane, discarding cleavage of
HCV RNA by the endogenous RNase P. In the right panel of
Figure 8B, hybridization with the speciﬁc HCV probe
Figure8.RNasePdoesnotcleaveHCV50 tRNA-likemotifinthecytoplasmoftransfectedcells.(A)SchematicrepresentationoftheplasmidusedtotesttheRNaseP
cleavageinthecytoplasm.HCVminimaldomain(WT)cleavedinvitrobyRNaseP(HCV299–408)wasinsertedinthecodingsequenceofCATinthepBICplasmid.
TheexpectedsizeoftheRNAfragments,ifcleavedbyRNaseP,isindicated.PositionsofhybridizationofCAT1–100andHCV299–408probesareindicatedindotted
line (CAT1–100andHCV,respectively).(B) Northernblot analysisaftertransfectionofBHK-21cells withpBIC-HCV.BHK-21cells were transfected withpBIC
plasmids containing (HCV) or not (pBIC) the HCV target for RNase P in vitro cleavage. pBIC plasmids were linearized by HpaI before transfection. Controls were
cellsnottransfected/infected(mock)orcellsnotinfected[VT7( )].TotalRNAwasextractedfromthecellsat16hpost-transfection,electrophoresed,transferedtoa
nylon membrane and hybridized with a pBIC-specific probe (CAT) or HCV-specific probe (HCV). The position of the ribosomal 28S and 18S RNA markers is
indicated on the right.
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absence of any new band relative to the pattern obtained with
the CAT probe.
Translation efficiency of the WT and
A368G sequences
The mutation of A368 to G in the ninth triplet of core coding
sequence does not change the encoded amino acid (arginine).
However, the effect of having two redundant signals that
mimic tRNA structure in an IRESelement was a novel feature,
with unpredictable consequences for translational activity.
Therefore, in order to assess whether the presence of a second
stable stem–loop structure immediately downstream of the
IRES region exerted an effect on the translational efﬁciency
of this RNA, we tested the ability of both WT and A368G
sequence to direct translation in both rabbit reticulocyte lysate
(RRL, in vitro) and in cell culture (BHK-21 cells, in vivo).
Bicistronic constructs have been proven useful to assay the
HCV viral IRES variants in BHK-21 cells infected with the
recombinant VT7F-3 vaccinia virus (28–30). Here, the bicis-
tronic transcripts contained the Renilla luciferase gene as a
ﬁrst cap-dependent reporter, and the Fireﬂy luciferase gene as
a second HCV IRES-dependent reporter (Figure 9A).
In vitro translation experiments were performed, in pres-
ence of Mg
2+ (0.5 mM), using RNAs previously transcribed
and quantiﬁed. The presence of A368G mutation reduces the
ability for the HCV IRES to direct translation (Figure 9B). In
RRL, the Fireﬂy luciferase expressed from mutated HCV
IRES is 52.9% compared to expression from WT IRES with-
out the mutation, and in BHK-21 transfected cells, 76.5%.
Thus, the A368G mutation slightly reduces the IRES activity
as compared to the wild-type sequence but does not prevent
translation initiation, indicating that the variant RNA present
in the viral quasispecies was being actively translated.
DISCUSSION
In this work, the minimal RNA fragment that confers access-
ibilitytohuman RNase Phasbeen foundto be located between
positions 299 and 408 of HCV consensus genome. After
processing the minimal HCV tRNA-like motif, it was found
that the longer portion (three-ﬁfths of the substrate) coincides
with part of domain IIIe, and domains IIIf and IV of the viral
IRES, whereas the shorter portion (two-ﬁfths of the substrate)
expands 30 outside the IRES region (Figure 1). The IIIe stem–
loop does not appear to be necessary for RNase P cleavage;
however, its participation in tRNA-like domain stabilization is
not excluded, since the speciﬁcity and efﬁciency of cleavage
are weakened in transcript 299–408 as compared to slightly
longer RNA substrates 291–418. Moreover, the complete
region that mimics the whole tRNA molecule may be larger
than the region that is recognized by RNase P (i.e. the T and
acceptor stems are enough for the RNase P recognition in its
natural pre-tRNA substrate) (Figure 10A) (13).
Lack of a common mutation proﬁle in the primary sequence
covered by the tRNA-like motif among or within different
viral quasispecies, and the fact that RNase P similarly recog-
nizes variants carrying mutations close to the cleavage site
suggest that the function exerted by this RNA motif is essen-
tial. Nevertheless, recognition of the tRNA-like domain was
compatible with structural variations in the motif that allowed
the formation of a second stem–loop near the cleavage site.
From the HCV population of sequences (quasispecies) present
in the serum of a single patient, we were able to isolate by an
in vitro selection method, a natural HCV RNA structural vari-
ant containing a mutation (A368G) close to the AUG initiation
codon that is present in 10% of the sequences in the serum
quasispecies. This mutation seemed to stabilize an alternative
RNA structure in comparison to the WT sequence, as meas-
ured by RNase H kinetics and accessibility to human RNase P.
It is worth noting that this variant RNA is translationally
active, albeit with a slightly reduced efﬁciency either in vitro
or in cell culture. As has been suggestedbefore (6,7,9),the ﬁrst
nucleotides of the core coding sequence seem to have an
important function in initiation of translation. Interestingly,
the AUG downstream coding sequences of other viral
IRESs, such as hepatitis A virus, GB virus B or Giardiavirus,
have also been involved in IRES-dependent translation (35–
37). However, conﬂicting results about the role played by this
region is found in the literature (4,38,39). The presence of
stable RNA structure downstream of the HCV AUG, different
from the one present in natural HCV genome, appears detri-
mental totranslation initiation(39).The ﬁndings of the present
study suggest that the tRNA-like domain in HCV RNA IRES
overlaps the AUG codon (nucleotide 342) including nucle-
otides from 299 to 408. The short hairpin found in the variant
sequence with enhanced RNase P accessibility, appears to be
a local internal RNA reorganization, not affecting either
the upstream AUG-hairpin or the downstream A-rich core
coding region. According to a previous report, the HCV
core coding sequence, but not the core protein, is involved
in IRES-dependent translation (39,40). Other works evidence
Figure 9. Effect of A368G mutation on IRES activity. (A) Diagram of the
bicistronicplasmidsusedforthetranslationassays.TheHCVRNAsequenceis
shown in a gray box (2–418).The first 26 amino acids of HCV core protein are
fused in frame with the firefly luciferase. (B) Comparison of WT and A368G
HCVIREStranslationefficiency.IRESactivitywasassessedbymeasuringthe
ratio of Firefly Luciferase to Renilla Luciferase produced from plasmids trans-
fected in BHK-21 cells or from in vitro transcribed RNA in rabbit reticulocyte
lysate (RRL).
Nucleic Acids Research, 2005, Vol. 33, No. 5 1499long-range RNA–RNA interactions between the core coding
sequence and the ﬁrst bases of the IRES, which seem also
detrimental to translation initiation (41,42). Thus, it seems that
the core coding sequence is actually involved in numerous
RNA secondary structures engaging various regions of the
entire IRES that regulate translation initiation, allowing the
virus to modulate its translational activity.
According to the data obtained by RNase P in vitro cleav-
age, we found that RNase P was recognizing a shorter 60 nt
RNA motif in the mutant sequence, internal to the minimal
fragment required for the predominant type. This represents
a natural variant with an embedded tRNA-like motif, in a
‘Russian-doll’-like conformation. Mapping the internal
motif with a battery of RNases indicates the probable forma-
tion in the mutant of a stable stem–loop two nucleotides down-
stream of the AUG containing stem–loop (Figure 7). We
compared this new RNase P 60 nt substrate with well-
known substrates of RNase P. The transcript containing the
two stem–loop structures in the A368G RNA (predicted in
silico and demonstrated biochemically in this work) can be
comparedtotheminimalstructurerequiredforRNasePrecog-
nition in its natural tRNA precursor substrate (Figure 10B
and C). A 30 nt external guide sequence (EGS) that is, a mini-
mized 3/4 EGS, seems sufﬁcient to guide RNase P cleav-
age to an RNA target (13,43,44). The 30 nt are distributed
as a ﬁrst stem formed by 7 nt complementary to the target
RNA, followed by the original T-stem–loop of the tRNA
precursor and 4 nt complementary to the RNA target,
which forms a second stem similar to the pre-tRNA stem of
the D stem–loop (Figure 10A and B). The structure predicted
for the minimum 60 nt HCV A368G RNA could resemble the
EGS structure because of the presence of a loop, the total
length of stem and stem–loop (9 nt separated by two unpaired
nucleotides), and the RNase P cleavage position (Figure 10,
compare B and C). Nevertheless, the HCV loop sequence is
very different from the well-conserved pre-tRNA stem–loop.
Additionally, the 4 nt forming the second stem in a typical
EGS are lacking in the HCV structure. Thus, the tRNA-like
motif present in 331–390 HCV A368G RNA seems to be a
new type of substrate for RNase P with a structure slightly
different from the well-known minimized 3/4 EGS.
It appears that none of the nucleotide preceding stem–loop
IV, which contains the AUG, are necessary for efﬁcient and
speciﬁc RNase P cleavage in the tRNA-like domain stabilized
Figure 10. Comparison of HCV A368G RNA structure to that of human RNase P minimal substrate. (A) Diagram of pre-tRNA cloverleaf structure. An arrow
indicates human RNase P cleavage site. Plain lines indicate the minimal structure necessary for RNase P recognition: acceptor stem, T stem–loop and D stem. (B)
Diagramofaminimizedexternalguidesequence(3/4EGS)hybridizedtoatargetRNAandrecognizedbyhumanRNaseP.(C)RepresentationofHCVA368GRNA
structure (nucleotides 331–390, from Figure 8) to allow a comparison with a 3/4 EGS. The arrow indicates RNase P cleavage site in HCV A368G RNA.
1500 Nucleic Acids Research, 2005, Vol. 33, No. 5by the A368G mutation. Thus, this novel tRNA-like structure
seems to be independent of stem–loop IIIe and of the well-
described pseudoknot structure, both of which would have
been good candidates for stabilization of a tRNA-like domain.
The ‘mutant’ tRNA-like domain appears as a ‘core’ domain of
60 nt composed of two stem–loops separated by two unpaired
nucleotide and followed by a stretch of 21 nt, that includes
the A-rich region, without a predictable secondary structure
(Figure 7). Since these 21 downstream nucleotides are neces-
sary for RNase P to cleave, they are likely to be involved in
RNase P recognition (39,45). Nevertheless, from the experi-
ments performed here, it is difﬁcult to explain why the variant
is a better substrate than the WT molecule.
We should note that the tRNA-like motif described here
seems to have a reverse orientation when compared to the
natural pre-tRNA substrate, where all the structural determ-
inants for RNase P recognition are located downstream from
the cleavage site (Figure 10A). This result led support to a
previous observation where after detecting stretches of
sequence conservation in the predicted RNA secondary struc-
ture of HCV and pestiviruses IRESes, Lyons and Robertson
proposed that most of the portion constituting the tRNA-like
motif detected in IRES of these viruses would precede the
cleavage site (12). We also observed that endogenous
RNase P did not cleave HCV RNA in transfected cells,
which suggests that RNase P is not involved in HCV cyto-
plasmic viral cycle. We therefore favor the idea that other
cellular factors involved in tRNA metabolism may recognize
the tRNA-like structure in HCV RNA. Taken together, all
these observations suggest that the major part of the tRNA-
like structure resides within the IRES and probably particip-
ates in its function in the manner of an RNA signal, as in other
molecular systems where tRNA-like structures are found (46).
The structure of viral RNA has been interpreted as an ele-
ment that imposes limitations on RNA genome evolution. To
off-balance this situation, viral IRESs present compensatory
mutations to preserve the higher order structures and their
binding to the ribosome (47). In this study, we recognize
within the viral quasispecies the presence of different con-
formations in a motif that is probably involved in IRES func-
tion. In agreement with this, the presence of this alternative
secondary structure does not prevent the IRES from directing
translation (see Figure 9). In this regard, the results shownhere
indicate that having two signals for RNase P recognition, i.e.
two tRNA-like motifs, is compatible with ribosome recogni-
tion but is not better than one signal for IRES activity. Thus,
we have an experimentally proven example of genotype–
phenotype relationship in RNA that might accommodate
most of the evolutionary implications applying to viral quas-
ispecies (48). The results presented in this work illustrate the
diversity that an RNA signal may adopt as a given entity in
viral RNAs.
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